AKT activation also induced sorafenib resistance in HCC by suppressing sorafenib-induced autophagic cell death [9,10] or by inducing forkhead box M1 expression via a transcription factor, activator protein 1 [11]. Here, AKT1 is linked to hepatocellular carcinoma.